Showing results (491-500 of 554) with videos related to
Sort By:
Pageof 56
Cell|November 19, 2013
Protective efficacy of a global HIV-1 mosaic vaccine against heterologous SHIV challenges in rhesus monkeysDan H Barouch, Kathryn E Stephenson, Erica N Borducchi, et al.The Lancet. HIV|February 21, 2020
Comparison of shortened mosaic HIV-1 vaccine schedules: a randomised, double-blind, placebo-controlled phase 1 trial (IPCAVD010/HPX1002) and a preclinical study in rhesus monkeys (NHP 17-22)Kathryn E Stephenson, Frank Wegmann, Frank Tomaka, et al.Cell Chemical Biology|August 16, 2023
Multimodal, broadly neutralizing antibodies against SARS-CoV-2 identified by high-throughput native pairing of BCRs from bulk B cellsGladys J Keitany, Benjamin E R Rubin, Meghan E Garrett, et al.The Journal of Infectious Diseases|October 31, 2022
SARS-CoV-2 Serosurveys: How Antigen, Isotype and Threshold Choices Affect the OutcomeRaquel A Binder, Gavin F Fujimori, Catherine S Forconi, et al.Medrxiv : the Preprint Server for Health Sciences|November 17, 2020
Epidemiological and immunological features of obesity and SARS-CoV-2Eric J Nilles, Sameed M Siddiqui, Stephanie Fischinger, et al.Nature Communications|February 16, 2021
Discrete SARS-CoV-2 antibody titers track with functional humoral stabilityYannic C Bartsch, Stephanie Fischinger, Sameed M Siddiqui, et al.Journal of Virology|May 26, 2018
Control of Heterologous Simian Immunodeficiency Virus SIVsmE660 Infection by DNA and Protein Coimmunization Regimens Combined with Different Toll-Like-Receptor-4-Based Adjuvants in MacaquesShakti Singh, Eric G Ramírez-Salazar, Rami Doueiri, et al.Mbio|January 25, 2022
Serological Markers of SARS-CoV-2 ReinfectionSameed M Siddiqui, Kathryn A Bowman, Alex L Zhu, et al.The Journal of Pediatrics|August 23, 2020
Pediatric Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Clinical Presentation, Infectivity, and Immune ResponsesLael M Yonker, Anne M Neilan, Yannic Bartsch, et al.Cell Reports. Medicine|September 6, 2021
Fab and Fc contribute to maximal protection against SARS-CoV-2 following NVX-CoV2373 subunit vaccine with Matrix-M vaccinationMatthew J Gorman, Nita Patel, Mimi Guebre-Xabier, et al.Pageof 56